Xeris Biopharma Holdings, Inc. (XERS)
5.97
+0.12
(+2.05%)
USD |
NASDAQ |
Apr 13, 16:00
5.99
+0.02
(+0.34%)
After-Hours: 04:44
Xeris Biopharma Holdings Cash from Investing (TTM) : -0.696M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| IDEXX Laboratories, Inc. | -136.24M |
| Zoetis, Inc. | -748.00M |
| Harrow, Inc. | -5.46M |
| Zymeworks, Inc. | 26.72M |
| Vir Biotechnology, Inc. | 310.37M |